APPLIED PRECLINICAL SCIENCE
EG-LAS Research & Development
The R&D division drives EG-LAS’s applied preclinical research agenda — designing and executing animal models, wound-healing and surgical studies, and pharmacological trials that generate scientifically sound, ethically governed data for the research community.
Driving Preclinical Innovation
Our **Research & Development** division bridges the critical gap between early-stage laboratory chemical discovery and clinical-phase pharmaceutical trials. We collaborate closely with Cairo University and leading national institutions.
Focus Areas
Study design, IACUC-compliant protocol development, surgical and pharmacological animal models, and cross-institutional research collaboration in laboratory animal science.
Preclinical Capabilities
Detailed list of specialized preclinical methodologies governed by our research experts.
1. Study Design & Ethical Review
Structuring preclinical studies from hypothesis to protocol, with ethical review built in from the start.
2. Surgical & Wound-Healing
Designing and executing surgical animal models, including wound-healing and tissue-repair studies.
3. Pharmacological Studies
Extract-based and pharmacological intervention studies evaluating therapeutic candidates in animal models.
4. Data Analysis & Reporting
Rigorous statistical analysis and scientific reporting that stands up to peer review.
5. IACUC Documentation
Full ethical approval documentation prepared for Cairo University’s IACUC and equivalent bodies.
6. Cross-Division Collaboration
Working alongside URAF and CTC-LAS to move research from design through facility execution.
Representative Research Areas
Standard disease and physiological pathways supported inside our labs.
A. Wound Healing Models
Tissue-defect and repair studies evaluating healing dynamics under controlled surgical conditions.
B. Endocrine & Hormonal
Induced-model studies examining hormonal conditions and candidate therapeutic responses.
C. Plant-Extract Interventions
Evaluating natural and plant-derived compounds as therapeutic interventions in animal models.
D. Pathology Models
Species-appropriate models investigating organ-specific conditions and treatment response.
Ethical Governance & RFQ Submission
Every R&D study is designed and reviewed under **Cairo University’s Institutional Animal Care and Use Committee (IACUC)** framework — ensuring welfare, scientific validity, and regulatory compliance are considered together from the earliest planning stage.
Study Design Consultation
Structuring preclinical studies from hypothesis to protocol with ethical review built in from the start. EG-LAS Research and Development division, Egypt.
Surgical & Wound-Healing Models
Design and execution of surgical animal models including wound-healing and tissue-repair studies, run by the EG-LAS preclinical R and D division.
EG-LAS Research & Development
**Affiliation:** Cairo University · Giza, Egypt
**Email:** rd@eglas.org.eg
**Email:** rd@eglas.org.eg
Ethical Governance
• CAIRO UNIVERSITY IACUC GOVERNED
Research Projects
Active and completed preclinical research projects run by the R&D division in collaboration with partner institutions.
No research papers available at the moment.
PRECLINICAL R&D REVIEWS
What Lead Investigators Say
★★★★★
Preclinical R&D Research“The preclinical pharmacokinetic and wound healing models executed by the EG-LAS R&D division yielded rigorous, publication-ready data accepted by top-tier Q1 journals without revisions.”
Prof. Dr. Ahmed Al-Ghamdi
Chair of Drug Discovery & Biotechnology
★★★★★
Preclinical R&D Research“Outstanding precision in protocol design, statistical reporting, and ethical IACUC compliance. EG-LAS is our trusted scientific partner for all our in-vivo validation and therapeutic studies.”
